Patent ID: 9249229
Filing Date: 2016-02-02
CPC Classification: C07K,G01N

Claim Text:
1. A fusion molecule comprising: a first portion that is an anti-CD200 antibody or antigen binding fragment thereof, comprising a light chain CDR1 having the sequence set forth in SEQ ID NO: 12; a light chain CDR2 having the sequence set forth in SEQ ID NO: 23; a light chain CDR3 having the sequence set forth in SEQ ID NO: 37; a heavy chain CDR1 having the sequence set forth in SEQ ID NO: 55; a heavy chain CDR2 having the sequence set forth in SEQ ID NO: 74; and a heavy chain CDR3 having the sequence set forth in SEQ ID NO: 93; and a second portion that is a toxin.